Stockreport

Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile [Seeking Alpha]

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations
PDF AMPH's revenue is propped up by BAQSIMI and PRIMATENE, while legacy generics decline and gross margins slip to 51.4%. Management's 2026 guidance for high single-digit [Read more]